Weighing Biovail's Claims

 

Using the same formula as above, this analysis yielded an estimate of 8.8 million Wellbutrin XL pills on the truck, equal to end-user sales of $25.1 million and Biovail royalty revenue of $4.2 million.

On Tuesday, Biovail shares rose 5 cents, or 0.2%, to $22.69. That's about 56% below the stock's 52-week high, reached prior to the truck accident that's still very much in question.

  • Loading Comments...
  •  
1 2 3 4 5
Next >

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
Adam Feuerstein writes regularly for RealMoney.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. He invites you to send your feedback.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,464.40 1,110.63 2,176.05 32.79
Oil *
77.05
UP
30.69
UP
4.98
UP
6.87
DOWN
0.38
10 Yr
3.28%
SPDR Gold
116.62
+0.29%
+0.45%
+0.32%
-1.15%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services